To determine the utility of KCNK9-US1 DMR methylation as an early breast cancer diagnostic, we tested whether hypomethylation was detectable prior to cancer diagnosis in high-risk women in morphologically normal breast tissue, or WBCs in women with invasive breast cancer. The gene discussed is KCNK9; the disease is breast cancer.